This antibody was purified from mouse ascites fluid using protein A agarose. This hybridoma was established by fusion of mouse myeloma cell P3U1 with Balb/c mouse splenocyte immunized with the recombinant full-length human RAIDD (200 a.a.).
Target:
RAIDD
Application Dilute:
WB: 1 µg/mL (chemiluminescence detection system)
* VAT and and shipping costs not included. Errors and price changes excepted